Public list cybersecurity (3154):
Dendrite enables sales, marketing, clinical and compliance solutions for the global pharmaceutical industry. In May 2007, Dendrite was acquired by Cegedim. The valuation of Dendrite was undisclosed. Other terms of the deal were not released.
1405 Hwy 206
New Jersey, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)